ACE Assay Kits

Assay Principle

Angiotensin-converting enzyme (ACE, also called ACE1 or kininase II) is a zinc metallopeptidase that converts angiotensin I to the vasoconstrictor angiotensin II and inactivates the vasodilator bradykinin. An ACE assay generally falls into one of two detection formats built around different synthetic substrates. Colorimetric kits commonly use FAPGG (N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine) as a substrate, which absorbs at 340 nm; ACE cleaves FAPGG into FAP and glycylglycine, and the resulting decrease in absorbance at 340 nm is tracked on a spectrophotometer or plate reader to calculate enzyme activity. Fluorometric kits instead rely on an o-aminobenzoyl (Abz)-based peptide substrate that releases a fluorophore upon cleavage, quantified with a fluorescence microplate reader (commonly around Ex/Em 320/420 nm), and both formats use a standard curve or positive control to convert the raw signal into activity units.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are typically formatted for 96-well microplates and validated against serum, plasma, and tissue homogenates, with lung, heart, and kidney among the more commonly referenced tissues given ACE's high expression in vascular endothelium. Total assay time tends to run from under an hour up to roughly two hours depending on the detection chemistry and whether a kinetic read is required. Sample dilution requirements vary by tissue and species, so manufacturers generally supply matrix-specific guidance rather than a single universal dilution factor. Reported sensitivity is often in the range of tens of milliunits of ACE activity per sample, though exact limits of detection differ across kits and should be checked against expected activity levels in the sample type of interest.

Assay Kit Purchasing Considerations

Detection chemistry is the most consequential difference between suppliers, since fluorometric Abz-based kits tend to offer greater sensitivity for low-activity ACE samples, while colorimetric FAPGG-based kits are simpler to run on standard absorbance instrumentation already common in most labs. Validated sample types and species reactivity also differ, so confirming that a kit has been tested in the relevant tissue or biofluid is worthwhile before committing to one format. Because these are enzymatic rather than antibody-based assays, substrate purity, reagent stability, and inclusion of a positive control and standard curve reagents matter more than lot-to-lot antibody variability, and these details are a reasonable proxy for overall kit quality. It is also worth checking whether a kit is designed to capture total ACE activity or is selective for a particular domain or isoform, since some formats are optimized for pharmacological inhibitor screening rather than general activity measurement. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.